Wedge Capital Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,362
Closed -$341K 419
2022
Q3
$341K Sell
4,362
-83
-2% -$6.63K 0.01% 332
2022
Q2
$301K Buy
4,445
+271
+6% +$18.9K ﹤0.01% 351
2022
Q1
$274K Sell
4,174
-1,169
-22% -$67.9K ﹤0.01% 368
2021
Q4
$324K Buy
5,343
+910
+21% +$54.3K ﹤0.01% 349
2021
Q3
$283K Buy
4,433
+706
+19% +$44.6K ﹤0.01% 350
2021
Q2
$234K Sell
3,727
-531
-12% -$33.3K ﹤0.01% 365
2021
Q1
$243K Sell
4,258
-2,318
-35% -$125K ﹤0.01% 476
2020
Q4
$331K Buy
+6,576
New +$262K ﹤0.01% 458

Other funds holding ACHC

Wedge Capital Management's ACHC Position: Q4 2022 in Review

Wedge Capital Management sold out of Acadia Healthcare (ACHC) in Q4 2022, closing a stake of 4,362 shares — an estimated $341K sold.

Wedge Capital Management first reported a position in ACHC in Q4 2020 and held it in 8 quarters. The position peaked at $341K in Q3 2022. 346 funds tracked by Wall St. Rank hold ACHC as of Q4 2022.

  • Wedge Capital Management reported no remaining Acadia Healthcare position as of Q4 2022 after selling out during the quarter.
  • Wedge Capital Management sold 4,362 Acadia Healthcare shares in Q4 2022, an estimated $341K.
  • Wedge Capital Management first reported a position in Acadia Healthcare in Q4 2020 and held it in 8 quarters.
  • Wedge Capital Management's Acadia Healthcare position peaked at $341K in Q3 2022.
  • 346 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2022.

Based on Wedge Capital Management's 13F filing for Q4 2022, filed 17 Jan 2023.